Clinical Trial Liability Insurance in Maryland

Maryland at a glance

Primary regulator

Maryland Insurance Administration

Oversees insurer licensing and policy form filings in the state.

Federal research proximity

Adjacent to NIH Bethesda campus and FDA headquarters

Drives a research base weighted toward federally funded and regulatory-facing studies.

Consent framework

State research-confidentiality protections layered on the federal Common Rule

Maryland requires specific data-use disclosures in research consent documentation.

Trial structure

Frequent multi-institution cooperative group studies

Common across university hospitals in Baltimore and the Washington suburbs.

NIH and FDA proximity shaping the research base

Maryland's location adjacent to NIH's Bethesda campus and FDA's headquarters gives the state a research environment weighted toward federally funded intramural studies, cooperative group trials, and regulatory-facing sponsor work that is less common in states without that federal footprint. A site running an NIH-funded protocol in Maryland should confirm how NIH's own indemnification framework for federal employees and grantees interacts with any commercial trial liability policy, since federal tort claims processes can apply differently than a standard sponsor indemnity clause.

Maryland's research confidentiality and consent framework

Maryland law includes specific confidentiality protections for research records and requires that consent documentation address how identifiable research data will be used and shared, layered on top of the federal Common Rule baseline. A Maryland site should confirm its consent template addresses these state-specific confidentiality assurances directly, since a form drafted purely to federal Common Rule specifications may not capture Maryland's added data-handling language.

Cooperative group and multi-institution trial structures

Maryland's academic and federal research density means many trials here run as multi-institution cooperative group studies rather than single-sponsor commercial trials, often coordinating across university hospitals in Baltimore and the Washington suburbs. That structure raises questions about which institution's insurance responds first when an incident occurs during a shared protocol, so cooperative group participation agreements should be reviewed specifically for how liability is allocated among the coordinating centers.

Building coverage around a federal-facing research base

A Maryland program should pair clinical trial liability with medical professional liability for investigators, coverage addressing cooperative group participation where relevant, and cyber coverage reflecting Maryland's confidentiality requirements for research records. Confirm current consent-content requirements and cooperative-group indemnity allocation with counsel, since federal funding structures can change how liability flows differently than in a purely commercial sponsor relationship.

Who we write this for in Maryland

Clinical trial liability FAQs for Maryland